Annotated somatic variants and interactive variant analysis results are available online atwww.ingenuity.com/acrg2012.
Eighty-eight primary HCC tumors and matched adjacent nontumor liver tissues were analyzed by whole-genome DNA sequencing to identify somatic mutations and HBV integration sites. The vast majority (92%,n = 81) of patients in this cohort were HBV carriers (i.e., HBsAg seropositive) suffering from chronic hepatitis B or cirrhosis. None of the patients were hepatitis C virus (HCV) positive
The original paper is here: http://www.ncbi.nlm.nih.gov/pubmed/23788652